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Abstract 
A 5-year-old boy was referred to our department for persistent epigastric discomfort. 
Serum gastrin level was 635 pg/ml with a pepsinogen (PG) I level of 102.7 ng/ml and a 
PG I/II ratio of 23.2, indicating a hyperacidic state. Upper gastrointestinal endoscopy 
showed normal gastric mucosal folds and no abnormalities including no gastric mucosal 
atrophy. To investigate the cause of hypergastrinemia, a Ca injection test was performed 
and the patient showed no definitive response to a large load of Ca. Contrast-enhanced 
dynamic CT revealed no space-occupying lesions. The results from these two studies 
were not consistent with the presence of gastrinoma. A urea breath test showed 2.8‰, 
and a test for the fecal H. pylori antigen was positive. Since H. pylori infection was 
considered to be a possible cause of hypergastrinemia, eradication therapy was 
introduced. The therapy was shown to be successful by using a repeated urea breath test 
that showed a normalization to 0.6‰. 7 months after the therapy blood examination 
showed a gastrin level of 191 pg/ml, a PG I level of 36.7 ng/ml, and a PG I/II ratio of 7.3. 
An immunostaining study of the gastric mucosa suggested that a decrease in 
somatostatin secretion due to a reduction in D cell population might have induced 
hypergastrinemia in this case. In children with H. pylori infection showing marked 
hypergastrinemia, immunohistochemical examination and therapeutic diagnosis by 
eradication may be helpful in the differential diagnosis of gastrinoma. 
Introduction 
Hypergastrinemia is classified into a primary type, as observed in gastrinoma, and a 
secondary type mostly due to increased gastrin secretion in response to low gastric acid  
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levels. Helicobacter pylori has been described as a causative agent in some cases of 
hypergastrinemia. Infection can occur in early childhood, and inappropriate 
hypergastrinemia has been shown in asymptomatic healthy subjects with H. pylori 
infection [1]. When the pyloric antrum is infected with H. pylori, G cells can be 
stimulated by bacterial ammonia or by gastric mucosal cytokines produced in response to 
H. pylori infection. Alternatively, somatostatin production by D cells can be impaired by 
H. pylori infection, and a decrease in somatostatin secretion can induce increasing gastrin 
secretion. 
We examined a young child with persistent epigastric discomfort and failure to thrive 
that we concluded was likely due to H. pylori infection. Although gastric anatomy was 
normal, the serum gastrin levels in the patient were markedly elevated and a differential 
diagnosis of gastrinoma was considered to be necessary. Based on the results of the 
patient’s response to a Ca injection test and the clinical course after eradication treatment 
for H. pylori infection, a diagnosis of secondary hypergastrinemia associated with 
H. pylori infection was confirmed. 
Case Report 
A 5-year-old boy presented with epigastric discomfort in the summer of 2008. The symptom was 
marked during fasting, especially at dawn, and relieved after meals. Neither loss of appetite nor diarrhea 
were noted, but there had been no weight gain during the preceding year. Due to the persistent 
epigastric discomfort, he was taken to an outpatient clinic and an antiemetic was started with no 
favorable effect. He was referred to our department for further examination. His parents and an elder 
sister had no history of gastric/duodenal diseases. On admission, his height was 111 cm and body weight 
was 18.3 kg. The palpebral conjunctiva was not anemic, and epigastric tenderness was noted. The serum 
gastrin level was 635 pg/ml, the maximum value during the course of treatment being 1,680 pg/ml 
(fig. 1). Serum pepsinogen (PG) I level was 102.7 ng/ml and the PG I/II ratio was 23.2, indicating a 
hyperacidic state. The normal values reported in children are: gastrin 92.5 ± 39.7 pg/ml, PG I 37.4 ± 
13.0 ng/ml, and PG I/II ratio 5.8 ± 1.6 [2]. Upper gastrointestinal endoscopy showed normal gastric 
mucosal folds and no abnormalities including no gastric mucosal atrophy. Pathological examination 
revealed a mild degree of inflammatory cell infiltration in the gastric mucosa. Administration of an H2 
blocker (1 mg/kg/day) was started for epigastric discomfort. 
To investigate the cause of hypergastrinemia, a Ca injection test was performed [3]. Ca was infused 
over 3 h at a rate of 4.0 mg/kg/h. In cases with gastrinoma, gastrin levels continuously increase in 
response to Ca injection. However, in this patient, the gastrin level did not change with Ca injection, 
showing no definitive response to a large load of Ca in 3 h. In addition, contrast-enhanced dynamic CT 
revealed no space-occupying lesions. The results from these two studies were not consistent with the 
presence of gastrinoma. A urea breath test showed 2.8‰ (normal range <2.5‰), and a test for the fecal 
H. pylori antigen was positive. Since H. pylori infection was considered to be a possible cause of 
hypergastrinemia, eradication therapy was performed (fig. 1). A proton pomp inhibitor (rabeprazole, 
0.5 mg/kg/day), AMPC (50 mg/kg/day), and metronidazole (20 mg/kg/day) were administered for 
14 days. The efficacy of eradication therapy was assessed after 2 months by using a repeated urea breath 
test that showed a normalization to 0.6‰. Endoscopy 5 months after therapy revealed a decrease in 
gastric mucosal folds while pathological examination showed a decrease in inflammatory cell 
infiltration. 7 months after therapy, blood examination showed a gastrin level of 191 pg/ml, a PG I level 
of 36.7 ng/ml, and a PG I/II ratio of 7.3. After the eradication, the epigastric pain gradually disappeared. 
To clarify the role of somatostatin secretion in the gastric mucosa in this patient, immunostaining of 
the gastric mucosa with an anti-gastrin antibody and anti-somatostatin antibody was performed before 
eradiation therapy. G and D cells were counted at 400-fold magnification, based on the method of Czaja 
et al. [4]. A gastric mucosal specimen was examined and compared to another specimen from a 
7-year-old girl who had no abnormalities detected by endoscopy or by pathological examination. The 
specimen from this patient showed average numbers of 78 G cells and 24 D cells from 3 high-power 
visual fields, and a G/D cell ratio of 3.25. The specimen from the control patient showed 76 G cells,  
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62 D cells, and a G/D cell ratio of 1.22. In the Czaja report, the mean G cell count was 79, D cell count 
45, and G/D cell ratio 1.79 in the normal controls [4]. The immunostaining study showed that the D cell 
count in this patient was lower than in controls, resulting in an increased G/D ratio. 
Discussion 
When food enters the stomach, gastrin is secreted by G cells in the pyloric antrum and 
via the circulation acts on gastrin receptors of parietal cells in the gastric body, inducing 
gastric juice secretion from these parietal cells. When food is propelled into the 
duodenum, secretin is secreted by duodenal mucosal cells and promotes somatostatin 
secretion by D cells in the gastric body. Via somatostatin, both gastrin secretion by G cells 
and gastric juice secretion by parietal cells are inhibited [5]. 
Hypergastrinemia is classified into a primary type, as observed in gastrinoma, and a 
secondary type mostly due to increased gastrin secretion in response to low gastric acid 
levels [1]. In this patient, because an abnormally elevated serum gastrin level with absence 
of gastric mucosal atrophy was noted, the possibility of gastrinoma was considered.  
The diagnosis of gastrinoma is often difficult to confirm due to its small size. In 
addition, there are no established criteria for the diagnosis of gastrinoma, and it is made 
after a comprehensive evaluation based on the following examinations: serum gastrin, 
secretin injection test, Ca injection test, and angiography. Hypergastrinemia showing a 
serum gastrin level of more than 10 times the normal upper limit strongly suggests the 
presence of gastrinoma. However, 2/3 of cases of gastrinoma show a gastrin level less than 
10 times the normal upper limit. The secretin injection test could not be performed 
because secretin was not available in Japan at the time of study. The Ca injection test 
shows significant increases in serum gastrin level in patients with gastrinoma compared 
to controls. A previous study showed a positive increase in serum gastrin in 80% of 
patients with gastrinoma [6]. Since pancreatic endocrine tumors are generally 
hypervascular, angiography is also useful for their evaluation. However, its sensitivity and 
specificity are not high (less than 80% for each). In this patient, the gastrin level was 
abnormally elevated, but the presence of gastrinoma was considered to be unlikely based 
on the results of imaging studies and the Ca injection test. 
The following hypothesis has been proposed: When the pyloric antrum is infected with 
H. pylori, G cells are stimulated by ammonia produced from the bacterium or by gastric 
mucosal cytokines such as IL-8 and TNF-α that are produced in response to H. pylori 
infection. Alternatively, D cell function, including somatostatin production, is impaired 
by H. pylori infection. As a result, gastrin secretion is promoted and causes hyperacidity 
[7]. It is also speculated that a decrease in somatostatin secretion, one of the factors 
inhibiting acid secretion, is the main cause of hyperacidity in H. pylori infection. A 
comparison of the G/D cell ratio between our study and that by Czaja et al. [4] showed no 
increase in G cells but a decrease in D cells resulting in a high G/D ratio in our patient. 
Thus, a decrease in somatostatin secretion due to a reduction in D cell population might 
have induced hypergastrinemia in this case. 
The diagnosis of gastrinoma is generally difficult and needs a multi-faceted approach. 
In some cases, gastrin secretion tests using Ca or secretin should be performed while in 
other cases contrast CT should be done. In children with H. pylori infection showing a 
high gastrin level requiring differentiation from gastrinoma, immunohistological  
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examination of the gastric mucosa to identify gastrin-secreting cells and somatostatin-
secreting cells to confirm a relative decrease in somatostatin production might be helpful 
in explaining hypergastrinemia. In addition, confirmation of a decrease in serum gastrin 
levels by eradication therapy in patients with H. pylori infection may also be feasible as a 
therapeutic diagnosis for excluding gastrinoma. In cases with a pending diagnosis of 
gastrinoma, repeated contrast-enhanced CT examination involving a high level of X-ray 
exposure is not desirable during childhood. In children with H. pylori infection showing a 
marked hypergastrinemia, immunohistochemical examination and therapeutic diagnosis 
by eradication may be helpful in the differential diagnosis of gastrinoma. 
 
 
 
 
 
 
Fig. 1. The clinical course of the patient that features the changes in serum gastrin levels is shown from 
the time of referral to our center. The values of serum PG I levels and the PG I/II ratio that were 
measured at the same time of gastrin measurement are also shown in the bottom of the figure. UBT = 
Urea breath test; EGF = esophagogastric fiberscopy; PPI = proton pomp inhibitor; PG = pepsinogen. 
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